These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 24355811)

  • 1. Climate for innovation, 12-step orientation, and tobacco cessation treatment.
    Muilenburg JL; Laschober TC; Eby LT
    J Subst Abuse Treat; 2014 Apr; 46(4):447-55. PubMed ID: 24355811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Organizational factors as predictors of tobacco cessation pharmacotherapy adoption in addiction treatment programs.
    Muilenburg JL; Laschober TC; Eby LT
    J Addict Med; 2014; 8(1):59-65. PubMed ID: 24365803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Organizational change in a perinatal treatment setting: integration of clinical practice and policies on tobacco and smoking cessation.
    Jessup MA
    J Psychoactive Drugs; 2007 Dec; 39(4):461-72. PubMed ID: 18303703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perceptions of the state policy environment and adoption of medications in the treatment of substance use disorders.
    Knudsen HK; Abraham AJ
    Psychiatr Serv; 2012 Jan; 63(1):19-25. PubMed ID: 22227755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sustained, new, never, and discontinued tobacco cessation services adopters.
    Eby LT; Laschober TC; Muilenburg JL
    J Subst Abuse Treat; 2015 Feb; 49():8-14. PubMed ID: 25178991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perceived implementation of the Office of Alcoholism and Substance Abuse Services (OASAS) tobacco-free regulation in NY State and clinical practice behaviors to support tobacco cessation: a repeated cross-sectional study.
    Eby LT; Laschober TC
    J Subst Abuse Treat; 2013 Jul; 45(1):83-90. PubMed ID: 23375360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of and Factors Related to Tobacco Ban Implementation in Substance Use Disorder Treatment Programs.
    Muilenburg JL; Laschober TC; Eby LT; Moore ND
    Adm Policy Ment Health; 2016 Mar; 43(2):241-9. PubMed ID: 25677250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicians' perceptions of implementation extensiveness of 100% tobacco free practices: a longitudinal study of New York state.
    Eby LT; Laschober TC
    J Behav Health Serv Res; 2014 Jan; 41(1):50-63. PubMed ID: 23430285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Institutional and economic influences on the adoption and extensiveness of managerial innovation in hospitals: The case of reengineering.
    Walston SL; Kimberly JR; Burns LR
    Med Care Res Rev; 2001 Jun; 58(2):194-228; discussion 229-33. PubMed ID: 11398646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sustainment of smoking cessation programs in substance use disorder treatment organizations.
    Knudsen HK; Muilenburg J; Eby LT
    Nicotine Tob Res; 2013 Jun; 15(6):1060-8. PubMed ID: 23132659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Innovation attributes and adoption decisions: perspectives from leaders of a national sample of addiction treatment organizations.
    Knudsen HK; Roman PM
    J Subst Abuse Treat; 2015 Feb; 49():1-7. PubMed ID: 25218918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A systematic review of the relationship between staff perceptions of organizational readiness to change and the process of innovation adoption in substance misuse treatment programs.
    Kelly P; Hegarty J; Barry J; Dyer KR; Horgan A
    J Subst Abuse Treat; 2017 Sep; 80():6-25. PubMed ID: 28755775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Understanding counselors' implementation of tobacco cessation services with patients.
    Eby LT; Laschober TC; Muilenburg JL
    J Subst Abuse Treat; 2014; 47(5):314-20. PubMed ID: 25082757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Facility-level, state, and financial factors associated with changes in the provision of smoking cessation services in US substance abuse treatment facilities: Results from the National Survey of Substance Abuse Treatment Services 2006 to 2012.
    Cohn A; Elmasry H; Niaura R
    J Subst Abuse Treat; 2017 Jun; 77():107-114. PubMed ID: 28476262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Training community-based treatment providers to implement contingency management for opioid addiction: Time to and frequency of adoption.
    Helseth SA; Janssen T; Scott K; Squires DD; Becker SJ
    J Subst Abuse Treat; 2018 Dec; 95():26-34. PubMed ID: 30352667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Counselor and clinical supervisor perceptions of OASAS tobacco-free regulation implementation extensiveness, perceived accountability, and use of resources.
    Laschober TC; Eby LT
    J Psychoactive Drugs; 2013; 45(5):416-24. PubMed ID: 24592668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural and cultural barriers to the adoption of smoking cessation services in addiction treatment organizations.
    Knudsen HK; Studts JL; Boyd S; Roman PM
    J Addict Dis; 2010 Jul; 29(3):294-305. PubMed ID: 20635279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adoption of system strategies for tobacco cessation by state medicaid programs.
    Bellows NM; McMenamin SB; Halpin HA
    Med Care; 2007 Apr; 45(4):350-6. PubMed ID: 17496719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implementation of smoking cessation treatment in substance use disorder treatment settings: a review.
    Knudsen HK
    Am J Drug Alcohol Abuse; 2017 Mar; 43(2):215-225. PubMed ID: 27314884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Smoking and Tobacco-Free Policies in Women's Residential Substance Use Disorder Treatment Facilities: A Community-Engaged Approach.
    Fallin-Bennett A; Parker KA; Miller A; Ashford K; Hahn EJ
    Nicotine Tob Res; 2018 Sep; 20(11):1386-1392. PubMed ID: 29059449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.